Valeant Sues Teva over Onexton Generics By Sam | March 17, 2017 Valeant’s Dow Pharmaceuticals filed a lawsuit against Teva’s Actavis, alleging infringement of two patents on the acne drug Onexton. Source: Drug Industry Daily Posted in Drug Industry Daily